COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,435 Articles (22,835 medRxiv, 8,600 bioRxiv)

Most recent first Previous |  Page 726: Articles 7251-7260  | Next

COVID-19 Vaccination Uptake and Self-Reported Side Effects among Healthcare Workers in Mbale City Eastern Uganda
Akech, G. M. M., Kanyike, A. M., Nassozi, A. G., Aguti, B., Nakawuki, A. W., Kimbugwe, D., Kiggundu, J., Maiteki, R., Mukyala, D., Bongomin, F., Obakiro, S. B., Rebecca, N., Iramiot, J. S.
10.1101/2022.07.11.22277490 — Posted: 2022-07-12
Microbubbles for improved nucleic acid extraction in wastewater samples for viral RNA detection
Wegner, C. J., Roussey, J., Carey, M., Macintyre, B., Snow, T., Sieglaff, D., Bridi, A., Battiste, S., Livi, C. B., McNaughton, B.
10.1101/2022.07.10.22277342 — Posted: 2022-07-12
Multi-omics provide evidence for an anti-inflammatory immune signature and metabolic alterations in patients with Long COVID Syndrome; an exploratory study
Kovarik, J. J., Bileck, A., Hagn, G., Meier-Menches, S. M., Frey, T., Kaempf, A., Hollenstein, M., Shoumariyeh, T., Skos, L., Reiter, B., Gerner, M. C., Spannbauer, A., Hasimbegovic, E., Schmidl, D., Garhoefer, G., Gyoengyoesi, M., Schmetterer, K. G., Gerner, C.
10.1101/2022.07.11.22277499 — Posted: 2022-07-12
Protection of SARS-CoV-2 natural infection against reinfection with the BA.4 or BA.5 Omicron subvariants
Altarawneh, H. N., Chemaitelly, H., Ayoub, H., Hasan, M. R., Coyle, P., YASSINE, H. M., Al Khatib, H. A., Benslimane, F., Al-Kanaani, Z., Al Kuwari, E., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul Rahim, H. F., Nasrallah, G., Al Kuwari, M. G., Butt, A. A., Al Romaihi, H. E., Al-Thani, M. H., Al Khal, A., Bertollini, R., Tang, P., Abu-Raddad, L. J.
10.1101/2022.07.11.22277448 — Posted: 2022-07-12
A RT-qPCR system using a degenerate probe for specific identification and differentiation of SARS-CoV-2 Omicron (B.1.1.529) Variants of Concern
Jessen, R., Nielsen, L., Larsen, N. B., Cohen, A., Gunalan, V., Marving, E., Alfaro-Nunez, A., Polacek, C., The Danish COVID-19 Genome Consortium (DCGC), , Fomsgaard, A., Spiess, K.
10.1101/2022.07.10.22277465 — Posted: 2022-07-12
COVID-19 Causes Ciliary Dysfunction as Demonstrated by Human Intranasal Micro-Optical Coherence Tomography Imaging
Vijaykumar, K., Leung, H. M., Barrios, A., Fernandez-Petty, C. M., Solomon, G. M., Hathorne, H. Y., Wade, J. D., Monroe, K., Slaten, K. B., Li, Q., Leal, S. M., Moates, D. B., Pierce, H. M., Olson, K. R., Currier, P., Foster, S., Marsden, D., Tearney, G. J., Rowe, S. M.
10.1101/2022.07.08.499336 — Posted: 2022-07-11
Landscape of infection enhancing antibodies in COVID-19 and healthy donors
Ismanto, H. S., Xu, Z., Saputri, D. S., Wilamowski, J., Li, S., Nugraha, D. K., Horiguchi, Y., Okada, M., Arase, H., Standley, D. M.
10.1101/2022.07.09.499414 — Posted: 2022-07-11
Evolution of SARS-CoV-2 during the first year of the COVID-19 pandemic in Northwestern Argentina
Zambrana Montano, R., Culasso, A., Fernandez, F., Marquez, N., Debat, H., Salmeron, M., Zamora, A. M., Ruiz de Huidobro, G., Costas, D., Alabarse, G., Charre, M., Fridman, A., Mamani, C., Vaca, F., Maza Diaz, C., Raskovsky, V., Lavaque, E., Lesser, V., Cajal, P., Aguero, F., Calvente, C., Torres, C., Viegas, M.
10.1101/2022.07.08.499374 — Posted: 2022-07-11
The impact of COVID-19 on prescribing of pancreatic enzyme replacement therapy for people with unresectable pancreatic cancer in England. A cohort study using OpenSafely-TPP
Lemanska, A., Andrews, C. D., Fisher, L., Butler-Cole, B., Mehrkar, A., Roberts, K. J., Goldacre, B., Walker, A. J., MacKenna, B.
10.1101/2022.07.08.22277317 — Posted: 2022-07-10
Modeling infections and deaths averted due to COVID-19 vaccination strategies in Ghana
Ofori, S. K., Schwind, J. S., Sullivan, K. L., Chowell, G., Cowling, B. J., Fung, I. C.-H.
10.1101/2022.07.09.22277458 — Posted: 2022-07-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).